BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25168278)

  • 21. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
    Wu H; Li D; Fang M; Han H; Wang H
    J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.
    Bielecka-Dabrowa A; Goch JH; Rysz J; Maciejewski M; Desai R; Aronow WS; Banach M
    Lipids Health Dis; 2010 Feb; 9():21. PubMed ID: 20178563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
    Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic infections can decrease the threshold of statin-induced muscle injury.
    Mahboobi SK; Shohat EZ; Jellinek SP; Rose M
    South Med J; 2006 Apr; 99(4):403-4. PubMed ID: 16634254
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.
    Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R
    Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting.
    Ji Q; Mei Y; Wang X; Sun Y; Feng J; Cai J; Xie S; Chi L
    Circ J; 2009 Dec; 73(12):2244-9. PubMed ID: 19822977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure.
    Duan HY; Liu DM; Qian P; Wang SL; Yan LJ; Wu JT; Yang HT; Fan XW; Chu YJ
    Genet Mol Res; 2015 Dec; 14(4):15739-48. PubMed ID: 26634541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
    Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
    JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
    Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
    Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
    Kruger PS; Harward ML; Jones MA; Joyce CJ; Kostner KM; Roberts MS; Venkatesh B
    Am J Respir Crit Care Med; 2011 Mar; 183(6):774-81. PubMed ID: 20959555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of early statin treatment on inflammatory biomarkers and clinical deterioration in patients with acute ischemic stroke].
    Sakurai K; Isahaya K; Takaishi S; Kato B; Shimizu K; Shimomura K; Tokuyama Y; Hasegawa Y
    Rinsho Shinkeigaku; 2011 Jan; 51(1):6-13. PubMed ID: 21387693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial.
    Ludman AJ; Hausenloy DJ; Babu G; Hasleton J; Venugopal V; Boston-Griffiths E; Yap J; Lawrence D; Hayward M; Kolvekar S; Bognolo G; Rees P; Yellon DM
    Basic Res Cardiol; 2011 Nov; 106(6):1387-95. PubMed ID: 21833652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.